Bortezomib maintenance therapy in transplant-ineligible myeloma patients who plateaued after bortezomib-based induction therapy: a multicenter phase II clinical trial

JOURNAL ARTICLE published July 2018 in International Journal of Hematology

Authors: Atsushi Isoda | Kayoko Murayama | Shigeki Ito | Yoichi Kohara | Masaki Iino | Yuri Miyazawa | Morio Matsumoto | Hiroshi Handa | Yosuke Imai | Takuro Ishiguro | Wataru Izumita | Kiyoshi Kitano | Yukio Hirabayashi | Hideyuki Nakazawa | Fumihiro Ishida | Toru Mitsumori | Keita Kirito | Takaaki Chou | Hirokazu Murakami | For the Kanshinetsu Multiple Myeloma Study Group